ABBV vs. PG: AbbVie vs. Procter & Gamble Stock Comparison

November 11, 2026

How do AbbVie (ABBV) and Procter & Gamble (PG) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

AbbVie (ABBV) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Procter & Gamble (PG) belongs to Consumer Staples (Household & Personal Products) — their GICS classifications point to very different parts of the market.

Company profile comparison for AbbVie (ABBV) and Procter & Gamble (PG)
Profile Item	ABBV	PG
Name	AbbVie Inc.	The Procter & Gamble Company
Country/Region	United States	United States
GICS Sector	Health Care	Consumer Staples
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences	Household & Personal Products
GICS Industry	Biotechnology	Household Products
GICS Sub-Industry	Biotechnology	Household Products
Market Capitalization	514.92 billion USD	383.36 billion USD
Currency	USD	USD
Exchange	NYSE	NYSE
Listing Date	January 2, 2013	January 2, 1962
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

ABBV

GSPC

AbbVie (ABBV) vs. Procter & Gamble (PG), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for AbbVie (ABBV) and Procter & Gamble (PG). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for AbbVie (ABBV) and Procter & Gamble (PG). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for AbbVie (ABBV) and Procter & Gamble (PG)
Metric	ABBV	PG
Total Return (1Y)	37.33%	17.45%
Total Return (3Y, Annualized)	32.74%	6.50%
Total Return (5Y, Annualized)	24.73%	5.59%

Risk Profile

Drawdown History

ABBV

GSPC

AbbVie (ABBV) vs. Procter & Gamble (PG), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for AbbVie (ABBV) and Procter & Gamble (PG). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for AbbVie (ABBV) and Procter & Gamble (PG)
Metric	ABBV	PG
Volatility (1Y, Annualized)	25.65%	21.15%
Beta (5Y)	0.21	0.35
Max Drawdown (5Y)	-21.92%	-23.77%
Avg. Volume (3M)	4.76M	9.19M

Risk-Adjusted Performance

Risk-Return Positioning

ABBV and PG are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for AbbVie (ABBV) and Procter & Gamble (PG)
Metric	ABBV	PG
Sharpe Ratio (1Y)	1.29	0.62
Sortino Ratio (1Y)	2.02	0.96

Profitability

ROE (TTM)

Capital efficiency shows on one side only: Procter & Gamble (PG) earns 29.61% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

Max: 109.18%
Q3: 6.23%
Median: -26.66%
Q1: -64.05%
Min: -167.77%
ABBV: --

PG

Household & Personal Products industry group

29.61%

Max: 42.18%
Q3: 31.87%
PG: 29.61%
Median: 17.80%
Q1: 9.28%
Min: -14.64%

AbbVie (ABBV) vs. Procter & Gamble (PG): ABBV does not report ROE, so it has no value marker; PG is benchmarked against the Household & Personal Products industry group.

Net Margin (TTM)

For every dollar of sales, both AbbVie (ABBV) at 15.67% and Procter & Gamble (PG) at 18.23% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

15.67%

Max: 18.05%
ABBV: 15.67%
Q3: 4.78%
Median: 0.00%
Q1: -4.14%
Min: -17.05%

PG

Household & Personal Products industry group

18.23%

Max: 23.47%
PG: 18.23%
Q3: 12.19%
Median: 8.50%
Q1: 3.08%
Min: -9.74%

AbbVie (ABBV) vs. Procter & Gamble (PG): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Operating Margin (TTM)

Procter & Gamble (PG) at 26.87% shows unusually strong operating efficiency — above its industry’s operating margin range — and AbbVie (ABBV) at 39.59% also operates in the top quartile.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

39.59%

Max: 83.12%
ABBV: 39.59%
Q3: 14.77%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

PG

Household & Personal Products industry group

26.87%

PG: 26.87%
Max: 23.94%
Q3: 17.03%
Median: 13.15%
Q1: 10.58%
Min: 1.87%

AbbVie (ABBV) vs. Procter & Gamble (PG): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Profitability Metrics

Profitability metrics for AbbVie (ABBV) and Procter & Gamble (PG)
Metric	ABBV	PG
ROE (TTM)	--	29.61%
ROA (TTM)	10.74%	10.49%
Net Margin (TTM)	15.67%	18.23%
Operating Margin (TTM)	39.59%	26.87%
Gross Margin (TTM)	73.72%	50.59%

Growth

Revenue Growth

Procter & Gamble (PG) at 3.26% sits in the top revenue growth quartile, while AbbVie (ABBV) at 8.57% is closer to the peer norm — faster top-line expansion for PG.

AbbVie (ABBV) vs. Procter & Gamble (PG): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both AbbVie (ABBV) at -0.84% and Procter & Gamble (PG) at 1.69% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

AbbVie (ABBV) vs. Procter & Gamble (PG): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for AbbVie (ABBV) and Procter & Gamble (PG)
Metric	ABBV	PG
Revenue Growth (YoY)	8.57%	3.26%
Revenue Growth (3Y CAGR)	1.75%	2.00%
EPS Growth (YoY)	-0.84%	1.69%
EPS Growth (3Y CAGR)	-29.03%	3.91%

Financial Strength

Current Ratio (MRQ)

Both AbbVie (ABBV) at 0.87 and Procter & Gamble (PG) at 0.72 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.87

Max: 25.13
Q3: 12.13
Median: 5.52
Q1: 2.47
ABBV: 0.87
Min: 0.10

PG

Household & Personal Products industry group

0.72

Max: 4.26
Q3: 2.82
Median: 1.84
Q1: 0.92
PG: 0.72
Min: 0.65

AbbVie (ABBV) vs. Procter & Gamble (PG): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Debt / Equity (MRQ)

Only one side’s leverage can be read here: Procter & Gamble (PG) carries debt-to-equity ratio of 0.70 against its industry range, while AbbVie (ABBV) reports no figure this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

Max: 1.42
Q3: 0.65
Median: 0.15
Q1: 0.02
Min: 0.00
ABBV: --

PG

Household & Personal Products industry group

0.70

Max: 2.30
Q3: 2.12
Median: 0.81
PG: 0.70
Q1: 0.50
Min: 0.01

AbbVie (ABBV) vs. Procter & Gamble (PG): ABBV does not report debt-to-equity ratio, so it has no value marker; PG is benchmarked against the Household & Personal Products industry group.

Financial Strength Metrics

Financial strength metrics for AbbVie (ABBV) and Procter & Gamble (PG)
Metric	ABBV	PG
Current Ratio (MRQ)	0.87	0.72
Debt / Equity (MRQ)	--	0.70
Net Debt / EBITDA	2.21	0.94

Dividends

Dividend Yield (TTM)

Procter & Gamble (PG) at 2.57% earns its spot in the top quartile of its industry’s yields; AbbVie (ABBV) at 2.40% is past the top of its own peer range — territory where a dividend-safety check matters more than the headline number.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40%

ABBV: 2.40%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

PG

Household & Personal Products industry group

2.57%

Max: 5.00%
PG: 2.57%
Q3: 2.47%
Median: 1.30%
Q1: 0.00%
Min: 0.00%

AbbVie (ABBV) vs. Procter & Gamble (PG): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Dividend Payout Ratio (TTM)

AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile Procter & Gamble (PG) reports 64.62%, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

117.35%

ABBV: 117.35%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

PG

Household & Personal Products industry group

64.62%

Max: 140.00%
Q3: 73.75%
PG: 64.62%
Median: 46.43%
Q1: 0.00%
Min: 0.00%

AbbVie (ABBV) vs. Procter & Gamble (PG): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Dividend Metrics

Dividend metrics for AbbVie (ABBV) and Procter & Gamble (PG)
Metric	ABBV	PG
Dividend Yield (TTM)	2.40%	2.57%
Dividend Payout Ratio (TTM)	117.35%	64.62%

Valuation

P/E Ratio (TTM)

Procter & Gamble (PG) at 24.91 is near its industry’s usual P/E ratio, while AbbVie (ABBV) at 50.05 sits in the richer quartile — ABBV needs stronger growth or earnings quality to justify the premium.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

50.05

Max: 85.34
ABBV: 50.05
Q3: 43.46
Median: 26.69
Q1: 13.30
Min: 0.07

PG

Household & Personal Products industry group

24.91

Max: 37.57
Q3: 33.54
PG: 24.91
Median: 20.03
Q1: 15.76
Min: 6.45

AbbVie (ABBV) vs. Procter & Gamble (PG): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

P/S Ratio (TTM)

AbbVie (ABBV) at 7.80 is priced about in line with its industry on P/S ratio, while Procter & Gamble (PG) at 4.36 sits in the pricier quartile — PG costs more per dollar of sales.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.80

Max: 58.18
Q3: 25.77
ABBV: 7.80
Median: 7.30
Q1: 3.01
Min: 0.01

PG

Household & Personal Products industry group

4.36

PG: 4.36
Max: 4.36
Q3: 3.57
Median: 1.68
Q1: 0.76
Min: 0.30

AbbVie (ABBV) vs. Procter & Gamble (PG): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

P/B Ratio (MRQ)

AbbVie (ABBV) reports a negative P/B ratio of -112.34, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Procter & Gamble (PG) reports 7.05, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

-112.34

Max: 13.53
Q3: 6.54
Median: 3.25
Q1: 1.69
Min: -5.59
ABBV: -112.34

PG

Household & Personal Products industry group

7.05

Max: 12.30
Q3: 7.43
PG: 7.05
Median: 3.44
Q1: 1.30
Min: -3.91

AbbVie (ABBV) vs. Procter & Gamble (PG): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Household & Personal Products industry group benchmarks.

Valuation Metrics

Valuation metrics for AbbVie (ABBV) and Procter & Gamble (PG)
Metric	ABBV	PG
P/E Ratio (TTM)	50.05	24.91
P/S Ratio (TTM)	7.80	4.36
P/B Ratio (MRQ)	-112.34	7.05
Free Cash Flow Yield (TTM)	3.44%	3.30%